Coronary Endothelial Dysfunction in People Living With HIV Is Related to Body Fat Distribution

Erin Goerlich1, Michael Schär2, Shashwatee Bagchi3

  • 1Division of Cardiology, Johns Hopkins University, Baltimore, MD.

Insights

Body fat distribution, including waist and hip measurements and subcutaneous fat, is linked to impaired coronary artery endothelial function (CEF) in people living with HIV (PLWH) on antiretroviral therapy (ART). This finding may explain the higher heart disease risk in PLWH.

Area of Science:

  • Cardiology
  • Endocrinology
  • Public Health

Background:

  • People living with HIV (PLWH) on antiretroviral therapy (ART) face elevated risks of atherosclerotic disease.
  • Abnormal adipose tissue distribution is prevalent in PLWH and may promote atherosclerosis.
  • Coronary artery endothelial function (CEF) impairment is an early sign of atherosclerosis and a predictor of cardiovascular events, and it is reduced in PLWH.

Purpose of the Study:

  • To investigate the associations between body fat distribution and coronary artery endothelial function (CEF) in people living with HIV (PLWH).

Main Methods:

  • A prospective cohort study involving 84 PLWH on stable ART.
  • Magnetic Resonance Imaging (MRI) was used to quantify CEF and abdominal fat distribution (visceral and subcutaneous) and liver fat fraction.
  • Linear regression models were employed to analyze the relationships between CEF and body fat measurements.

Main Results:

  • Impaired CEF was observed in the study population (mean cross-sectional area change: 0.74 ± 11.7%).
  • Univariable analysis revealed inverse associations between CEF and waist circumference, hip circumference, and subcutaneous fat area.
  • Multivariable regression, adjusted for age, sex, and race, showed CEF was associated with waist circumference, hip circumference, subcutaneous fat, and liver fat fraction.

Conclusions:

  • Waist and hip circumference and subcutaneous fat area are associated with impaired CEF in PLWH on ART.
  • These associations may contribute to the increased incidence of heart disease observed in this population.
  • Body fat distribution is a significant factor in vascular health among PLWH.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
234
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
73
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
56
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
172
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
731
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
326